Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

OBJECTIVE: We compared the metabolic and cardiovascular parameters of a reference group of women with those of women who used 2 contraceptive regimes that are used worldwide: the levonorgestrel-releasing intrauterine device and oral contraceptives. STUDY DESIGN: We investigated a cohort of 2814 wom...

Full description

Bibliographic Details
Main Authors:	Morin-Papunen, L, Martikainen, H, McCarthy, M, Franks, S, Sovio, U, Hartikainen, A, Ruokonen, A, Leinonen, M, Laitinen, J, Järvelin, MR, Pouta, A
Format:	Conference item
Published:	2008

Similar Items

Should long-term hormonal contraception be reconsidered? Metabolic and inflammatory outcomes in women using oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
by: Morin-Papunen, L, et al.
Published: (2006)

Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
by: Koivunen, R, et al.
Published: (2008)

Contraception: efficacy and safety of levonorgestrel-releasing intrauterine system
by: T Yu Pestrikova, et al.
Published: (2015-02-01)

Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
by: Taponen, S, et al.
Published: (2004)

Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms.
by: Laitinen, J, et al.
Published: (2003)

Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism.
by: Torvinen, A, et al.
Published: (2011)

No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth.
by: Bennett, A, et al.
Published: (2008)

Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
by: Taponen, S, et al.
Published: (2004)

Manifestations of metabolic syndrome after hypertensive pregnancy.
by: Pouta, A, et al.
Published: (2004)

PPARG P12A,Kir6.2/KCNJ11 E23K and early growth in the Northern Finland Birth Cohort of 1966
by: Bennett, A, et al.
Published: (2005)

No association between insulin gene variation and adult metabolic phenotypes in a large Finnish birth cohort.
by: Bennett, A, et al.
Published: (2005)

Detailed analysis of variation at and around mitochondrial position 16189 in a large Finnish cohort reveals no significant associations with early growth or metabolic phenotypes at age 31 years.
by: Das, S, et al.
Published: (2007)

Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling
by: Costescu DJ
Published: (2016-10-01)

Variation at the insulin gene VNTR (variable number tandem repeat) polymorphism and early growth: studies in a large Finnish birth cohort.
by: Bennett, A, et al.
Published: (2004)

Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS.
by: Barber, T, et al.
Published: (2007)

Serum sex hormone-binding globulin and testosterone in relation to cardiovascular disease risk factors in young men: a population-based study.
by: Canoy, D, et al.
Published: (2014)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
by: Marcia Vieira da Motta, et al.
Published: (2013-01-01)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
by: Marcia Vieira da Motta, et al.
Published: (2013-06-01)

Contraception with levonorgestrel-releasing intrauterine system versus copper intrauterine device: a meta-analysis of randomized controlled trialsResearch in context
by: Pan Liu, et al.
Published: (2024-12-01)

Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
by: Elaine Cristina Fontes de Oliveira, et al.
Published: (2023-12-01)

Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort.
by: Vääräsmäki, M, et al.
Published: (2009)

Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS
by: Limei Ji, et al.
Published: (2023-12-01)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
by: Hira Imad Cheema, et al.
Published: (2017-11-01)

Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.
by: Barber, T, et al.
Published: (2007)

Maternal gestational diabetes and the manifestations of metabolic syndrome in adolescent offspring
by: Pouta, A, et al.
Published: (2006)

Reversible Cerebral Vasoconstriction Syndrome Associated with Levonorgestrel-Releasing Intrauterine System
by: Sangwon Choi, et al.
Published: (2021-05-01)

Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma
by: Ching-Jung Lin, et al.
Published: (2018-02-01)

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
by: Chandra Kailasam, et al.
Published: (2008-10-01)

Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 Birth Cohort study.
by: Tzoulaki, I, et al.
Published: (2008)

The lost intrauterine levonorgestrel-releasing system in women with adenomyosis: A case report
by: Eka Rusdianto Gunardi, et al.
Published: (2022-11-01)

Marked increase of breast density due to a levonorgestrel-releasing intrauterine device
by: J Gossner
Published: (2013-11-01)

#378 : Intrauterine Suture of Levonorgestrel Intrauterine Device Under Hysteroscopy
by: Xiaoyu Shi, et al.
Published: (2023-12-01)

Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
by: Sharad Iyengar, et al.
Published: (2022-01-01)

Weight at birth and infancy in relation to adult leukocyte count: a population-based study of 5619 men and women followed from the fetal period to adulthood.
by: Canoy, D, et al.
Published: (2009)

Study of Efficacy and Acceptability of Levonorgestrel-Releasing Intrauterine Device in Heavy Menstrual Bleeding Patients
by: Robina Kousar, et al.
Published: (2024-08-01)

An Interesting Image of Transmural Migration of a Levonorgestrel-Releasing Intrauterine Device (LNg-IUD)
by: Melinda-Ildiko Mitranovici, et al.
Published: (2022-09-01)

Hysteroscopic suture of levonorgestrel-releasing intrauterine system: learning curve for in vitro simulation training
by: JinCheng Huang, et al.
Published: (2023-10-01)

An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis
by: Huizhi Zhang, et al.
Published: (2022-11-01)

Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
by: Barbara Zantut Wittmann, et al.
Published: (2020-05-01)

Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.
by: Gaasenbeek, M, et al.
Published: (2004)